KCPG
RMD icon

Kavar Capital Partners Group’s ResMed RMD Stock Holding History

Kavar Capital Partners Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40
Closed -$1K – 368
2014
Q1 		$1K Hold
40
– – ﹤0.01% 468
2013
Q4 		$1K Buy
+40
New +$2.02K ﹤0.01% 443

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kavar Capital Partners Group's RMD Position: Q2 2014 in Review

Kavar Capital Partners Group sold out of ResMed (RMD) in Q2 2014, closing a stake of 40 shares — an estimated $1K sold.

Kavar Capital Partners Group first reported a position in RMD in Q4 2013 and held it in 2 quarters. The position peaked at $1K in Q1 2014. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2014.

  • Kavar Capital Partners Group reported no remaining ResMed position as of Q2 2014 after selling out during the quarter.
  • Kavar Capital Partners Group sold 40 ResMed shares in Q2 2014, an estimated $1K.
  • Kavar Capital Partners Group first reported a position in ResMed in Q4 2013 and held it in 2 quarters.
  • Kavar Capital Partners Group's ResMed position peaked at $1K in Q1 2014.
  • 312 funds tracked by Wall St. Rank held ResMed as of Q2 2014.

Based on Kavar Capital Partners Group's 13F filing for Q2 2014, filed 25 Jan 2019.